Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Radiologists (US)(?)

Council Members in this Study Group: 660

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

John Hewett, MD
Partner
Pacific Interventional

J. Joseph Hewett, MD is the Medical Director of Vascular Access Centers of South Los Angeles, Vascular Access Center of Los Angeles, and Newport Cancer Care Diagnostic Imaging and Interventions. He is a managing partner in Pacific Interventional which operates outpatient vascular access centers and...

Johnson Lightfoote, MD, MBA
Medical Director of Radiology
Pomona Valley Hospital Medical Center

Johnson Lightfoote, MD, MBA, is Medical Director of Radiology at Pomona Valley Hospital Medical Center and past Medical Director of University of Southern California University Hospital. His responsibilities include management of imaging services; implementation of major projects, including PACS, CT,...

Martin Fuss, MD
Radiation Oncologist
OREGON HEALTH & SCIENCE UNIVERSITY - CC

Martin Fuss, MD, is a Professor and Program Director of Image-Guided Radiation Therapy (IGRT) in the Department of Radiation Medicine at Oregon Health and Science University. Previously, Dr. Fuss was an Associate Professor in the Department of Radiation Oncology at University of Texas Health Science...

Sasa Mutic, MS, Associate Professor of Radiation Oncology , Washington University in St. Louis-School of MedicineSasa Mutic, MS
Associate Professor of Radiation Oncology
Washington University in St. Louis-School of Medicine

Sasa Mutic, MS, is the Chief of Clinical Medical Physics and Associate Professor of Radiation Oncology at Mallinckrodt Institute of Radiology at Washington University School of Medicine, Missouri. His main clinical and research interests include implementation of different medical imaging modalities...

Marc Hamet, MD, President, Image Guided Therapeutics, LLC.Marc Hamet, MD
President
Image Guided Therapeutics, LLC.

Marc Hamet, MD, is the Director of Vascular and Interventional Radiology at Stamford Hospital in Connecticut. He is also the President at Image Guided Therapeutics, LLC. Dr. Hamet is board certified in Diagnostic and Interventional Radiology and Neuroradiology. His areas of expertise include vertebroplasty,...

Eric Choi, MD
Assistant Professor of Surgery and Radiology
Washington University in St. Louis-School of Medicine

Eric Choi, MD, is an Associate Professor of Surgery and Radiology at Washington University School of Medicine, Missouri. Dr. Choi has expertise in the treatment of wide variety of vascular diseases including aortic aneurysm, carotid artery disease, peripheral arterial diseases, and venous diseases....

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Velcade has multiple efficcay | 09-15-2008
Author: GLG Expert Contributor

It is very good news atht Velcade approved for previously untreated multiple Myeloma. Velcade has multiple efficacy as treatmnet is concerned for other diseases too ( Diabetes-II, Cardiovascular disease) as the mechanism of action is same for those target ( proteasome  inhibitors).

Onglyza (saxagliptin) has a great scope for Diabetes-II | 09-11-2008
Analysis of: BMS, AstraZeneca present saxagliptin data | www.fiercebiotech.com
Author: GLG Expert Contributor

Saxagliptin has good positive resluts in Phase-III trial.Still noe there i snor side effect reported. Thsi drug will compete  with Januvia ( merck). But Saxagliptin is better situtaion as the mechanism of action is concerned on DPP-4.

This is bad news for Cell Genesys but may use for other treatment | 08-29-2008
Author: GLG Expert Contributor

 1. Radioimmunoassay is very hard to  proof the basic biology of metastatic patient. 2.  GVAX  Immunotherapy is basically modify the  GM-CSF, so the exact biology of immune system of the patient  should be considered in metastatic stage before use. As the tumor is already...

Temozolomide and Thalidomide combination therapy for Malignant Melanoma | 08-26-2008
Author: GLG Expert Contributor

1.  The phase II clinical trial  of the combination thherapy of ( temozolomide and Thalidomide for Malignant Melanoma is very encourganing. It may open new avenue to treat   malignant melanoma  affecting Brain. 2. This  article is important for use  of combination...

The FInal Cervical cancer Vaccine is media hype | 08-22-2008
Author: GLG Expert Contributor

1.  Merck and GSK are pushing too much for Cerival cancer vaccine advertisement. 2.  Merck ( Gardasil), and GSK( cervarix) are very tiny age applications, but real disease start after 20, so early vaccination is no use, but Pap smear is more helpful 3. So drug marker push to cancer vaccine lead...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Academic Institution*

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Director
  • Physician - Division Head
  • Professor
  • Physician - Department Chair
  • President
  • Partner

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-04T21:45:18.380